ABSTRACT
Cellular migration is a ubiquitous feature that brings brain cells into appropriate spatial relationships over time; and it helps in the formation of a functional brain. We studied the migration patterns of induced pluripotent stem cell (IPSC)-derived neural precursor cells (NPCs) from individuals with familial bipolar disorder (BD), in comparison with healthy control. The BD patients also had morphological brain abnormalities in magnetic resonance imaging. Time-lapse analysis of migrating cells was conducted, through which we were able to identify several parameters to be abnormal in cellular migration, including the speed and directionality of NPCs. We also performed transcriptomic analysis to probe the mechanisms behind aberrant cellular phenotype identified. Our analysis showed downregulation of a network of genes, centering on EGF/ERBB proteins. Present findings indicate that collective, systemic dysregulation may produce the aberrant cellular phenotype; which could contribute to the functional and structural changes in the brain, reported in bipolar disorder.
SUMMARY STATEMENT We report abnormal cell migration patterns in neural precursors derived from bipolar disorder patients, which could contribute to already known structural changes in the brain.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a grant from the Department of Biotechnology (DBT) (India) funded grants- Accelerating program for discovery in brain disorders using stem cells (BT/PR17316/MED/31/326/2015) (ADBS); the Department of Science and Technology, Targeted generation and interrogation of cellular models and networks in neuro-psychiatric disorders using candidate genes (BT/01/CEIB/11/VI/11/2012); Imaging-genomics approach to identify molecular markers of Lithium response in Bipolar disorder, through the Department of Science and Technology (India) - INSPIRE Faculty Fellowship awarded to Dr. Biju Viswanath (Project number 00671, Code: IFA-12-LSBM-44); Science & Engineering Research Board (India) project Dissecting the biology of lithium response in human induced pluripotent stem cell derived neurons from patients with bipolar affective disorder (ECR/2016/002076); and Deciphering the mechanisms of lithium response in patients with bipolar disorder through the DBT/ Wellcome Intermediate (Clinical and Public Health) Fellowship awarded to Dr. Biju Viswanath (IA/CPHI/20/1/505266). The results of this work have been partially presented as a poster in the conference- at XXVIIIth World Congress of Psychiatry Genetics, 2020, and also received the Hugh Gurling award 2020.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol has been approved by the ethics committee of the National Institute of Mental Health and Neurosciences, Bengaluru, India (No. NIMHANS/DO/96TH lEC/2015). Clinical protocol for this study conforms to the ethical norms and standards in the Declaration of Helsinki. Committee decision: protocol approved Committee members: 1. Dr. AK Kurpad, Professor of Physiology, NIMHANS; Chair, Ethics committee 2. Mr. AR Patil, Professor, National Law School of India; legal expert on the Ethics committee 3. Dr. Dennis Xavier, Prof. & Head, Dept of Pharmacology, St. John's Medical College 4. Dr. Rajaram Subbian, social scientist on the ethics committee 5. Dr. Pratima Murthy, Dept. of Psychiatry, NIMHANS 6. Dr. Pramod Pal, Dept. of Neurology, NIMHANS 7. Dr. M. Jayaram, Dept of Speech Pathology & Audiology 8. Dr. V. Ravi, Dept. of Neurovirology, NIMHANS 9. Dr. B.N. Gangadhar, Dept. of Psychiatry, NIMHANS
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵# Accelerator Program for Discovery in Brain disorders using Stem cells (ADBS) Consortium Biju Viswanath1, Naren P. Rao1, Janardhanan C. Narayanaswamy1, Palanimuthu T. Sivakumar1, Arun Kandasamy1, Muralidharan Kesavan1, Urvakhsh Meherwan Mehta1, Ganesan Venkatasubramanian1, John P. John1, Meera Purushottam1, Odity Mukherjee2, Bhupesh Mehta1, Thennarasu Kandavel1, B. Binukumar1, Jitender Saini1, Deepak Jayarajan1, A. Shyamsundar1, Sydney Moirangthem1, K. G. Vijay Kumar1, Jayant Mahadevan1, Bharath Holla1, Jagadisha Thirthalli1, Prabha S. Chandra1, Bangalore N. Gangadhar1, Pratima Murthy1, Mitradas M. Panicker3, Upinder S. Bhalla3, Sumantra Chattarji2, Vivek Benegal1, Mathew Varghese1, Janardhan Y. C. Reddy1, Raghu Padinjat3, Mahendra Rao2, Sanjeev Jain1,
1. National Institute of Mental Health and Neurosciences (NIMHANS), India
2. Institute for Stem Cell Biology and Regenerative Medicine (InStem), India
3. National Center for Biological Sciences (NCBS), India
Data Availability
Available upon request
